OracleBio is pleased to announce that Matthew Gaffney has recently joined the company as its Business Development Manager for the USA.
Matthew is a highly skilled business development manager with previous experience working for a number of contract research organisations in the USA. Currently based in Boston, Matt’s work will focus on expanding OracleBio’s customer base in the East Coast of America. Matt is an award-winning professional with a 19 year portfolio of success within the pharmaceutical and biotechnology industries.
OracleBio’s expansion into the US has come as the company has seen increased business in the USA, particularly in the Boston area. OracleBio’s Chief Operations Officer, John Waller, commented:
“OracleBio has experienced significant growth in the number of Clients within the USA requiring digital pathology support for their pre-clinical and clinical R&D projects. We are delighted to have Matt on board and see his role as a key component in further establishing our relationships with current Clients while raising the visibility of OracleBio’s services to new Clients across the USA.”
Welcome to the team Matt!